Journal of Nuclear Research and Applications

An International Double-Blind, Peer-Review Journal by NSTRI

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Publication Ethics and Malpractice Statement

Editorial Board

Indexing and Abstracting

Related Links

FAQ

News

Manuscript Preparation

Manuscript Submission

Format

Form

References Format

Peer Review Process

Subscription Fee

List of Reviewers

Web of Science (Publons)

Biodistribution and Human Absorbed Dose Evaluation of an Organic-Inorganic Nanocomposite Containing 198Au (198Au/PG4D)

Document Type : Research paper

Authors

1 Nuclear Fuel Cycle Research School, Nuclear Science and Technology Research Institute, 14155-1339, Tehran, Iran

2 Department of biochemistry, Faculty of Science, Zanjan University

Abstract

An organic-inorganic nanocomposite 198Au/PD4G was synthesize using polyamidoamine G4 dendrimer and applied as an anticancer agent against 4T1 carcinoma tumor as well as for biodistribution and human absorbed dose investigation. Radionuclide 198Au was produced by irradiation of natural gold (197Au) in a medium flux reactor with 3×1011n/cm2.s flux of thermal neutron. Gamma spectroscopy exhibited only one characteristic peak of 198Au at 411 KeV as well as a radiochemical purity of more than 82% (using ITLC) was obtained for final formulation of 198Au/PG4D (37MBq). A single intratumoral injection of 88μCi of 198Au/PG4D resulted statistically significant 65% reduction in 4T1 tumor volume after 20 days. Biodistribution investigations showed that the tumor had a maximum 198Au/PG4D uptake of 81.27% and 79.37% at 4 and 24 h post injection. The human’s absorbed dose, furthermore, was extrapolated via the biokinetics data of mice so that the doses absorbed in the critical organs such as the bone, lung, spleen, kidney, and liver are 0.0669, 1.1, 0.221, 0.0983 and 0.282 mGy/MBq, respectively.

Keywords

Main Subjects

References
  1. 1. Seong SK, Ryu JM, Shin DH, Bae EJ, Shigematsu A, Hatori Y, et al. Biodistribution and excretion of radioactivity after the administration of 166Ho-chitosan complex (DW-166HC) into the prostate of rat. European journal of nuclear medicine and molecular imaging. 2005;32(8):910-7.
  2. Song H-C, Kun N, Park K-H, Shin C-H, Bom H-S, DONGMIN K, et al. Intratumoral administration of rhenium-188-labeled pullulan acetate nanoparticles (PAN) in mice bearing CT-26 cancer cells for suppression of tumor growth. Journal of microbiology and biotechnology. 2006;16(10):1491-8.
  3. Bakker RC, Lam M, Nimwegen SAV, Rosenberg AJWP, Es RJJ, Nijsen JFW. Journal of Radiation Oncology, 6 323 (2017).
  4. Lee I, Lee YH. The effect of various therapeutic solutions including colloidal chromic 32P via an

        intratumoral injection on the tumor physiological parameters of AsPC-1 human pancreatic tumor xenografts in nude mice. Clinical Cancer Research. 1999;5(10):3139s-42s.

  1. Khan MK, Minc LD, Nigavekar SS, Kariapper MS, Nair BM, Schipper M, et al. Fabrication of {198 Au 0} radioactive composite nanodevices and their use for nanobrachytherapy. Nanomedicine: Nanotechnology, Biology and Medicine. 2008;4(1):57-69.
  2. K.C. Black, et al., ACS Nano, 8 4385 (2014).
  3. Rezaei R, Darzi SJ, Yazdani M, Anti cancer Agents Med Chem, 20 1250 (2020).
  4. Durymanov MO, Rosenkranz AA, Sobolev AS. Current approaches for improving intratumoral accumulation and distribution of nanomedicines. Theranostics. 2015;5(9):1007.
  5. Jiang W, Kim BY, Rutka JT, Chan WC. Nanoparticle-mediated cellular response is size-dependent. Nature nanotechnology. 2008;3(3):145-50.
  6. Narmani A, Arani MA, Mohammadnejad J, Vaziri AZ, Solymani S, Yavari K, Talebi F, Darzi SJ. Breast tumor targeting with PAMAM-PEG-5FU-99m Tc as a new therapeutic nanocomplex: in in-vitro and in-vivo studies. Biomedical Microdevices. 2020 Jun;22:1-3.
  7. Han H, Xing J, Chen W, Jia J, Li Q. Fluorinated polyamidoamine dendrimer-mediated miR-23b delivery for the treatment of experimental rheumatoid arthritis in rats. Nature Communications. 2023 Feb 20;14(1):944.
  8. Ernandes T, Daniel-da-Silva AL, Trindade T. Metal-dendrimer hybrid nanomaterials for sensing applications. Coordination Chemistry Reviews. 2022 Jun 1;460:214483.
  9. Walter KA, Tamargo RJ, Olivi A, Burger PC, Brem H. Intratumoral chemotherapy. Neurosurgery. 1995;37(6):1129-45.
  10. Voulgaris S, Partheni M, Karamouzis M, Dimopoulos P, Papadakis N, Kalofonos HP. Intratumoral doxorubicin in patients with malignant brain gliomas. American journal of clinical oncology. 2002 Feb 1;25(1):60-4.
  11. Lammers T, Peschke P, Kühnlein R, Subr V, Ulbrich K, Huber P, et al. Effect of intratumoral injection on the biodistribution, the therapeutic potential of HPMA copolymer-based drug delivery systems. Neoplasia. 2006;8(10):788-95.
  12. Pulaski BA, Terman DS, Khan S, Muller E, Ostrand-Rosenberg S. Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model. Cancer research. 2000;60(10):2710-5.
  13. Tao K, Fang M, Alroy J, Sahagian GG. Imagable 4T1 model for the study of late stage breast cancer. BMC cancer. 2008;8(1):228.
  14. Heppner GH, Miller FR, Shekhar PM. Nontransgenic models of breast cancer. Breast Cancer Research. 2000;2(5):331.
  15. Janitabar-Darzi S, Rezaei R, Yavari K. In vitro Cytotoxicity Effects of 197Au/PAMAMG4 and 198Au/PAMAMG4 Nanocomposites Against MCF7 and 4T1 Breast Cancer Cell Lines. Advanced pharmaceutical bulletin. 2017;7(1):87.
  16. Balogh L, Ganser T, Shi X, editors. Characterization of dendrimer-gold nanocomposite materials. Materials Research Society Symposium Proceedings; 2005: Warrendale, Pa.; Materials Research Society; 1999.
  17. Garcia ME, Baker LA, Crooks RM. Preparation and characterization of dendrimer− gold colloid nanocomposites. Analytical chemistry. 1999 Jan 1;71(1):256-8.
  18. Vredenburg MR, Ojima I, Veith J, Pera P, Kee K, Cabral F, et al. Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance. Journal of the National Cancer Institute. 2001;93(16):1234-45.
  19. Wang P, Zhao X-H, Wang Z-Y, Meng M, Li X, Ning Q. Generation 4 polyamidoamine dendrimers is a novel candidate of nano-carrier for gene delivery agents in breast cancer treatment. Cancer letters. 2010;298(1):34-49.
  20. Fathi F, Moghaddam-Banaem L, Shamsaei M, Samani A, Maragheh MG. Production, biodistribution, and dosimetry of 47Sc-1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetramethylene phosphonic acid as a bone-seeking radiopharmaceutical. Journal of Medical Physics/Association of Medical Physicists of India. 2015 Jul;40(3):156.
  21. Valentin J. Basic anatomical and physiological data for use in radiological protection: reference values: ICRP Publication 89. Annals of the ICRP. 2002;32(3):1-277.
  22. Deilami-nezhad L, Moghaddam-Banaem L, Sadeghi M. Development of bone seeker radiopharmaceuticals by Scandium-47 and estimation of human absorbed dose. Applied radiation and isotopes. 2017;129:108-16.
  23. Siegel JA, Thomas SR, Stubbs JB, Stabin MG. MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. The Journal of Nuclear Medicine. 1999;40(2):37S.
  24. Parsignault D. The Beta Spectrum of Au198, and the Conversion Coefficients of the 412-keV Line in Hg198. In Internal Conversion Processes 1966 Jan 1 (pp. 173-182). Academic Press.
  25. Tang MX, Redemann CT, Szoka FC. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjugate chemistry. 1996;7(6):703-14.
  26. Yuv S, Eyu G, Av S, Aa L, Iyu K, Nv P, Mi L. Experimental study of dendrimer-based nanoparticles with RGD-peptide for anticancer radionuclide therapy. Bulletin of Russian State Medical University. 2018(6):113-9.
  27. Liu H, Xu Y, Wen S, Chen Q, Zheng L, Shen M, et al. Targeted tumor computed tomography imaging using low‐generation dendrimer‐stabilized gold nanoparticles. Chemistry–A European Journal. 2013;19(20):6409-16.
  28. Aghaei-Amirkhizi N, Moghaddam-Banaem L, Athari-Allaf M, Sadjadi S, Johari-Daha F. Development of dendrimer encapsulated Radio-Ytterbium and biodistributionin tumor bearing mice. IEEE Transactions on NanoBioscience. 2016 Jul 7;15(6):549-54.
  29. Moghaddam-Banaem L, Amirkhizi NA, Sadjadi S, Johari-Deha F, Athari-Allaf M. The Preparation, Biodistribution, and Dosimetry of Encapsulated Radio-Scandium in a Dendrimer for Radio-nano-pharmaceutical Application. Iranian Journal of Pharmaceutical Research. 2022 Dec 31;21(1).
  30. Sonavane G, Tomoda K, Sano A, Ohshima H, Terada H, Makino K. In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. Colloids and Surfaces B: Biointerfaces. 2008 Aug 1;65(1):1-0.
  31. Sonavane G, Tomoda K, Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids and Surfaces B: Biointerfaces. 2008 Oct 15;66(2):274-80.
  32. T. Niidome, M. Yamagata, Y. Okamoto, Y. Akiyama, H. Takahashi, T. Kawano, Y. Katayama, Y. Niidome, Journal of Control Release 114 343 (2006).
  33. Moghaddam-Banaem L, Janitabar-Darzi S, Rezaei R. Biodistribution and human absorbed dose evaluation of an organic-inorganic nanocomposite containing 198 Au (198 Au/PG4D), JONRA.
  34. Owens III DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. International journal of pharmaceutics. 2006 Jan 3;307(1):93-102.

 

 

 

Journal of Nuclear Research and Applications
Volume 4, Issue 1 - Serial Number 10
February 2024
Pages 35-44
Files
Share
How to cite
Statistics